Higham C - Search Results

1

Natural history of non-functioning pituitary microadenomas: results from the UK non-functioning pituitary adenoma consortium.

Hamblin R, Fountas A, Lithgow K, Loughrey PB, Bonanos E, Shinwari SK, Mitchell K, Shah S, Grixti L, Matheou M, Isand K, McLaren DS, Surya A, Ullah HZ, Klaucane K, Jayasuriya A, Bhatti S, Mavilakandy A, Ahsan M, Mathew S, Hussein Z, Jansz T, Wunna W, MacFarlane J, Ayuk J, Abraham P, Drake WM, Gurnell M, Brooke A, Baldeweg SE, Sam AH, Martin N, Higham C, Reddy N, Levy MJ, Ahluwalia R, Newell-Price J, Vamvakopoulos J, Krishnan A, Lansdown A, Murray RD, Pal A, Bradley K, Mamoojee Y, Purewal T, Panicker J, Freel EM, Hasan F, Kumar M, Jose B, Hunter SJ, Karavitaki N. Hamblin R, et al. Among authors: higham c. Eur J Endocrinol. 2023 Jul 20;189(1):87-95. doi: 10.1093/ejendo/lvad070. Eur J Endocrinol. 2023. PMID: 37345849 Free article.

2

Hazards of slow-release preparations in patients with bowel strictures.

Shaffer JL, Higham C, Turnberg LA. Shaffer JL, et al. Among authors: higham c. Lancet. 1980 Aug 30;2(8192):487. doi: 10.1016/s0140-6736(80)91928-5. Lancet. 1980. PMID: 6106136 No abstract available.

3

Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.

Jaikaran ET, Higham CE, Serpell LC, Zurdo J, Gross M, Clark A, Fraser PE. Jaikaran ET, et al. Among authors: higham ce. J Mol Biol. 2001 May 4;308(3):515-25. doi: 10.1006/jmbi.2001.4593. J Mol Biol. 2001. PMID: 11327784

4

Oestradiol measurement during fulvestrant treatment for breast cancer.

Owen LJ, Monaghan PJ, Armstrong A, Keevil BG, Higham C, Salih Z, Howell S. Owen LJ, et al. Among authors: higham c. Br J Cancer. 2019 Feb;120(4):404-406. doi: 10.1038/s41416-019-0378-9. Epub 2019 Jan 25. Br J Cancer. 2019. PMID: 30679781 Free PMC article.

5

The antimalarial agent mefloquine inhibits ATP-sensitive K-channels.

Gribble FM, Davis TM, Higham CE, Clark A, Ashcroft FM. Gribble FM, et al. Among authors: higham ce. Br J Pharmacol. 2000 Oct;131(4):756-60. doi: 10.1038/sj.bjp.0703638. Br J Pharmacol. 2000. PMID: 11030725 Free PMC article.

6

Licorice - or more?

Leitolf H, Dixit KC, Higham CE, Brabant G. Leitolf H, et al. Among authors: higham ce. Exp Clin Endocrinol Diabetes. 2010 Apr;118(4):250-3. doi: 10.1055/s-0029-1224123. Epub 2010 Mar 8. Exp Clin Endocrinol Diabetes. 2010. PMID: 20213599

7

Preparation of synthetic human islet amyloid polypeptide (IAPP) in a stable conformation to enable study of conversion to amyloid-like fibrils.

Higham CE, Jaikaran ET, Fraser PE, Gross M, Clark A. Higham CE, et al. FEBS Lett. 2000 Mar 17;470(1):55-60. doi: 10.1016/s0014-5793(00)01287-4. FEBS Lett. 2000. PMID: 10722845 Free article.

8

Long-term experience of pegvisomant therapy as a treatment for acromegaly.

Higham CE, Chung TT, Lawrance J, Drake WM, Trainer PJ. Higham CE, et al. Clin Endocrinol (Oxf). 2009 Jul;71(1):86-91. doi: 10.1111/j.1365-2265.2008.03469.x. Epub 2008 Nov 5. Clin Endocrinol (Oxf). 2009. PMID: 19018786 Clinical Trial.

9

Successful use of weekly pegvisomant administration in patients with acromegaly.

Higham CE, Thomas JD, Bidlingmaier M, Drake WM, Trainer PJ. Higham CE, et al. Eur J Endocrinol. 2009 Jul;161(1):21-5. doi: 10.1530/EJE-08-0990. Epub 2009 May 1. Eur J Endocrinol. 2009. PMID: 19411301 Clinical Trial.

10

Effective combination treatment with cabergoline and low-dose pegvisomant in active acromegaly: a prospective clinical trial.

Higham CE, Atkinson AB, Aylwin S, Bidlingmaier M, Drake WM, Lewis A, Martin NM, Moyes V, Newell-Price J, Trainer PJ. Higham CE, et al. J Clin Endocrinol Metab. 2012 Apr;97(4):1187-93. doi: 10.1210/jc.2011-2603. Epub 2012 Jan 25. J Clin Endocrinol Metab. 2012. PMID: 22278424 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

158 results

Search Page